Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP381976.RABnB_Bk3v6nCtNOOXr6N3Xe8jhzAXbO6soncq-W4WzyM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP381976.RABnB_Bk3v6nCtNOOXr6N3Xe8jhzAXbO6soncq-W4WzyM130_assertion type Assertion NP381976.RABnB_Bk3v6nCtNOOXr6N3Xe8jhzAXbO6soncq-W4WzyM130_head.
- NP381976.RABnB_Bk3v6nCtNOOXr6N3Xe8jhzAXbO6soncq-W4WzyM130_assertion wasGeneratedBy ECO_0000203 NP381976.RABnB_Bk3v6nCtNOOXr6N3Xe8jhzAXbO6soncq-W4WzyM130_provenance.
- NP381976.RABnB_Bk3v6nCtNOOXr6N3Xe8jhzAXbO6soncq-W4WzyM130_assertion wasDerivedFrom befree-20140225 NP381976.RABnB_Bk3v6nCtNOOXr6N3Xe8jhzAXbO6soncq-W4WzyM130_provenance.
- NP381976.RABnB_Bk3v6nCtNOOXr6N3Xe8jhzAXbO6soncq-W4WzyM130_assertion SIO_000772 12242461 NP381976.RABnB_Bk3v6nCtNOOXr6N3Xe8jhzAXbO6soncq-W4WzyM130_provenance.
- NP381976.RABnB_Bk3v6nCtNOOXr6N3Xe8jhzAXbO6soncq-W4WzyM130_assertion evidence source_evidence_literature NP381976.RABnB_Bk3v6nCtNOOXr6N3Xe8jhzAXbO6soncq-W4WzyM130_provenance.
- NP381976.RABnB_Bk3v6nCtNOOXr6N3Xe8jhzAXbO6soncq-W4WzyM130_assertion description "[Ac-GIP and pGlu-GIP, show resistance to plasma dipeptidylpeptidase IV degradation, resulting in enhanced biological activity and improved antidiabetic potential in vivo, raising the possibility of their use in therapy of Type II (non-insulin-dependent) diabetes mellitus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP381976.RABnB_Bk3v6nCtNOOXr6N3Xe8jhzAXbO6soncq-W4WzyM130_provenance.